Evolution of induction chemotherapy in the pre- and post-taxane era for locally advanced laryngeal cancer: A National Cancer Data Base analysis.

e18080Background: TAX-323/324 showed improved response rate and overall survival (OS) with the addition of docetaxel (T) to induction cisplatin/5-FU (PF) prior to radiotherapy (ICRT) for stage III/...